Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCSNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GA.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.40NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.55NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HH.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.8.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.19NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FM.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
XBB.2.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.7.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.14NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.5.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.53NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EU.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CM.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.43NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.122.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.122.3 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.132 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.132 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.160.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.17NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.4.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used